Ares Financial Consulting
ATYR icon

Ares Financial Consulting’s aTyr Pharma ATYR Stock Holding History

Ares Financial Consulting’s Portfolio ATYR Stock Details ATYR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$606 Hold
50
– – ﹤0.01% 1022
2026
Q2 		$1.19K Hold
50
– – ﹤0.01% 978
2026
Q1 		$1.7K Buy
+50
New +$1.69K ﹤0.01% 874

Other funds holding ATYR

StoneX Group
StoneX Group New York $2.75B AUM 24.25% 1-Year Est. Return
Kingswood Wealth Advisors
Kingswood Wealth Advisors San Diego, California $2.6B AUM 27.46% 1-Year Est. Return
Alpha Wealth Funds
Alpha Wealth Funds Park City, Utah $167M AUM 5.57% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
Certuity
Certuity North Palm Beach, Florida $2.13B AUM 70.4% 1-Year Est. Return
Newbridge Financial Services Group
Newbridge Financial Services Group Boca Raton, Florida $868M AUM 42.47% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
EverSource Wealth Advisors
EverSource Wealth Advisors Birmingham, Alabama $3.11B AUM 21.48% 1-Year Est. Return
Root Financial Partners
Root Financial Partners Encinitas, California $2.98B AUM 13.9% 1-Year Est. Return

Ares Financial Consulting's ATYR Position: Q3 2026 in Review

Ares Financial Consulting held its aTyr Pharma (ATYR) position steady in Q3 2026 at 50 shares worth $606. The position accounts for ﹤0.01% of the portfolio, ranked #1022.

Ares Financial Consulting first reported a position in ATYR in Q1 2026 and has held it in 3 quarters since. The position peaked at $1.7K in Q1 2026. 17 funds tracked by Wall St. Rank hold ATYR as of Q3 2026.

  • Ares Financial Consulting held 50 shares of aTyr Pharma worth $606 as of Q3 2026.
  • Ares Financial Consulting left its aTyr Pharma share count unchanged in Q3 2026.
  • aTyr Pharma made up ﹤0.01% of Ares Financial Consulting's portfolio in Q3 2026, its #1022 holding.
  • Ares Financial Consulting first reported a position in aTyr Pharma in Q1 2026 and has held it in 3 quarters since.
  • Ares Financial Consulting's aTyr Pharma position peaked at $1.7K in Q1 2026.
  • 17 funds tracked by Wall St. Rank held aTyr Pharma as of Q3 2026.

Based on Ares Financial Consulting's 13F filing for Q3 2026, filed 19 Oct 2026.